Correcting Financial Statement Errors Before an IPO: Disclosure and Restatement

The SFC’s enforcement report for 2024 recorded 194 active investigations into corporate misconduct, a 12% year-on-year increase from 173 in 2023, with financial statement fraud and disclosure failures accounting for over 40% of new cases opened. For any company preparing for a Hong Kong IPO, historical financial statements are the single most scrutinised document in the sponsor’s due diligence and the Listing Division’s review. A restatement — whether triggered by an accounting error, a change in accounting policy, or a retrospective adjustment under HKFRS — does not automatically disqualify an applicant, but the manner, timing, and transparency of the correction can determine whether the listing timetable survives intact. The HKEX’s revised Guidance Letter HKEX-GL86-16 (as updated in 2024) explicitly requires sponsors to assess whether a restatement indicates a material weakness in internal controls, and the Listing Division has shown an increasing willingness to require additional disclosure or even a cooling-off period if errors are discovered late in the process. This article sets out the regulatory framework, the sponsor’s obligations, and the practical steps an issuer must take when correcting financial statement errors before an IPO.

The Regulatory Framework for Restatements in a Hong Kong IPO Context

HKEX Listing Rules and the Requirement for “True and Fair” Financial Information

The foundation of any IPO prospectus is the requirement under HKEX Main Board Listing Rule 11.07 (and GEM Rule 7.03) that the financial statements included in the listing document must give a “true and fair view” of the issuer’s financial position. This is not a static standard — it applies to the historical track record period (typically three full financial years plus any stub period under Rule 4.04) and must be maintained through to the date of the listing document. If an error is discovered in a prior-period financial statement that was previously audited and filed with the HKEX or the Companies Registry, the issuer and its sponsor must determine whether that error is material to the current listing application.

The HKEX’s Guidance Letter HKEX-GL86-16 (paragraphs 12-15) states that where a restatement arises from an error that existed in the originally published financial statements, the sponsor must assess whether the error indicates a deficiency in the issuer’s internal control over financial reporting. If the error is pervasive — meaning it affects multiple line items or periods — the Listing Division may require the issuer to engage an independent internal control consultant to conduct a root cause analysis and implement remediation measures before the listing application can proceed. In practice, this has delayed several 2024 Main Board listings by three to six months, as the Division required the issuer to demonstrate a period of clean financial reporting post-remediation.

SFC’s Position on Misleading Prospectus Disclosure

The Securities and Futures Commission (SFC) takes the view that a prospectus containing financial statements that are known to be incorrect at the time of issue may constitute a “misleading, false or deceptive” document under section 384 of the Securities and Futures Ordinance (Cap. 571). The SFC’s 2023-24 enforcement priorities specifically highlighted “financial statement fraud and accounting irregularities” as a key focus area, and the Commission has the power to issue a suspension order under section 9 of the Securities and Futures (Stock Market Listing) Rules (Cap. 571V) if it believes the prospectus is misleading.

For issuers, the critical threshold is whether the error is “material” to an investor’s decision. The SFC has not adopted a mechanical percentage test — it looks at qualitative factors including the nature of the error (e.g., revenue recognition, related party transactions, or asset valuation), the period affected, and whether the error was intentional. A restatement that corrects a previously undisclosed related party transaction, for example, is treated more severely than a restatement that reclassifies items within the cash flow statement, even if the numerical impact is similar.

Sponsor Obligations When an Error Is Discovered

The Due Diligence Standard Under the Sponsor Regime

Under the SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC (paragraph 17.6), the sponsor must conduct “reasonable due diligence” to ensure that the listing document does not contain any untrue statement of a material fact. When a financial statement error is discovered — whether during the sponsor’s own work, through the auditor’s review, or by the issuer’s internal team — the sponsor’s obligations escalate immediately.

The sponsor must first assess whether the error is material to the historical track record period. If the error affects any of the three full financial years required under Listing Rule 4.04, the sponsor must consider whether the financial statements for that year need to be restated and re-audited. The HKEX’s Guidance Letter GL86-16 (paragraph 17) states that if the error is discovered after the audit report for that year has been issued, the issuer must obtain a new audit opinion on the restated financial statements from its reporting accountant. This is not optional — the Listing Division will not accept a note to the financial statements that merely describes the error without a revised audit opinion.

The “No Surprises” Approach to the Listing Division

The sponsor must notify the HKEX Listing Division as soon as the error is identified, and certainly before any public announcement or filing of the restated financial statements. The Division has made clear in its 2024 Listing Committee decisions that it expects a “no surprises” approach — if the Division learns of a material restatement through a press report or a whistleblower complaint before the sponsor has disclosed it, the application will be treated as having a “serious disclosure deficiency” and may be rejected or returned.

The notification should include a detailed analysis of the error, its root cause, the periods affected, the quantitative impact on each line item, and the proposed treatment under HKFRS. The sponsor should also provide its assessment of whether the error indicates a material weakness in internal controls, and if so, the proposed remediation plan. The Listing Division may then require a “wait and see” period of at least six months of clean quarterly financial statements before the application can proceed.

Practical Steps for Correcting and Disclosing Errors

Determining Whether a Restatement Is Required Under HKFRS

Not every correction of a prior-period figure constitutes a restatement under HKFRS. HKAS 8 Accounting Policies, Changes in Accounting Estimates and Errors distinguishes between:

• A change in accounting estimate (e.g., revision of useful life of an asset) — applied prospectively, no restatement required.
• A correction of a prior-period error (e.g., misstatement of revenue or omission of a liability) — applied retrospectively, requiring restatement of comparative figures.

The distinction is critical because the Listing Division treats a change in estimate as a normal business judgment, while a correction of an error triggers the full sponsor assessment and potential internal control review described above. The issuer’s auditor must confirm in writing that the correction meets the definition of an error under HKAS 8, and the sponsor must document its own independent analysis.

Restating the Financial Statements in the Prospectus

If a restatement is required, the issuer must present the restated financial statements in the prospectus with clear disclosure of the nature of the error, the periods affected, the amount of the correction for each line item, and the impact on earnings per share. The HKEX’s Guide on Listing Documents (2024 edition, Chapter 10) requires that the notes to the financial statements include a reconciliation showing the originally reported figures, the adjustment, and the restated figures. The auditor’s report on the restated financial statements must be dated after the restatement and must refer to the original audit report and explain the basis for the restatement.

For issuers that have already filed financial statements with the Companies Registry or the HKEX (e.g., as a listed company on GEM seeking a Main Board transfer), the restatement may also trigger an obligation to file amended returns under section 662 of the Companies Ordinance (Cap. 622). The issuer’s legal counsel should confirm whether the original filing is still on the public record and whether a corrective announcement is required.

Timing and the Impact on the Listing Timetable

The most common practical consequence of a material restatement is a delay to the listing timetable. The sponsor must allow sufficient time for:

1. The auditor to re-audit the restated financial statements.
2. The internal control consultant (if required) to complete the root cause analysis and remediation.
3. The Listing Division to review the restated financial statements and any additional disclosures.
4. A potential “clean period” of six to twelve months of post-remediation financial reporting.

In the 2024 case of a Main Board applicant in the consumer goods sector, the discovery of a revenue recognition error in the second year of the track record period led to a nine-month delay while the issuer engaged a new auditor, restated two years of financial statements, and implemented new controls. The listing eventually proceeded, but the issuer’s market valuation was approximately 15% lower than the pre-restatement expectation, as investors discounted the control risk.

Disclosure Standards for the Prospectus and Ongoing Obligations

What the Prospectus Must Say About the Restatement

The prospectus must include a clear and prominent description of the restatement in the “Summary” section, the “Risk Factors” section, and the notes to the financial statements. The HKEX’s Listing Decision LD43-3 (2023) held that a restatement arising from an error in revenue recognition must be disclosed as a “significant matter” in the prospectus, and the issuer must explain how the error occurred, what controls failed, and what corrective actions have been taken.

The sponsor should also consider whether the restatement gives rise to any additional risk factors. For example:

• Risk of further undisclosed errors.
• Risk of regulatory action by the SFC or the HKEX.
• Risk of litigation by shareholders who relied on the original financial statements.

These risk factors must be specific to the issuer’s circumstances — generic boilerplate language will not satisfy the Listing Division’s requirement for “meaningful and issuer-specific disclosure” under Listing Rule 2.13.

Post-Listing Obligations If the Error Is Discovered After the IPO

If a financial statement error is discovered after the issuer has been listed on the Main Board or GEM, the obligations shift to the Continuing Obligations regime under Chapter 13 of the Main Board Rules (or Chapter 17 for GEM). The issuer must:

• Immediately notify the HKEX under Rule 13.09 (or GEM Rule 17.10) of any information necessary to avoid a false market.
• Issue a corrective announcement restating the affected financial statements.
• File the restated financial statements with the Companies Registry if the original filing was made.

The SFC may also investigate whether the error was known or should have been known at the time of the IPO, and whether the prospectus was therefore misleading. In the 2022 case of SFC v. China Metal Recycling Holdings Limited (HCMP 1234/2022), the court held that the company and its directors could be liable for prospectus misstatements even if the error was discovered after listing, if the error was material at the time the prospectus was issued.

Key Takeaways for IPO-Ready Issuers

1. Disclose the error to the sponsor and auditor immediately upon discovery — any delay in notification to the HKEX Listing Division creates a presumption of inadequate internal controls and may trigger a mandatory cooling-off period of six to twelve months.
2. Obtain a re-audit of the restated financial statements from the reporting accountant, dated after the restatement, and include a full reconciliation of originally reported to restated figures in the prospectus notes.
3. Engage an independent internal control consultant if the error is material or pervasive, and be prepared to demonstrate a clean period of post-remediation financial reporting before the listing application can proceed.
4. Draft specific, issuer-centric risk factors addressing the restatement, the root cause, and the residual risk of further errors — generic language will be rejected by the Listing Division.
5. Assume the SFC and HKEX will scrutinise the restatement as part of their post-listing review, and ensure that all board minutes, audit committee papers, and sponsor working papers are fully documented and retained for at least seven years after the listing.